Victory Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.3M Buy
221,844
+14,289
+7% +$342K ﹤0.01% 1301
2025
Q1
$5.16M Buy
207,555
+112,805
+119% +$2.8M 0.01% 1269
2024
Q4
$1.79M Sell
94,750
-27,478
-22% -$518K ﹤0.01% 1539
2024
Q3
$1.84M Buy
122,228
+34,589
+39% +$521K ﹤0.01% 1506
2024
Q2
$2.51M Buy
87,639
+13,776
+19% +$394K ﹤0.01% 1373
2024
Q1
$2.16M Buy
73,863
+8,299
+13% +$242K ﹤0.01% 1431
2023
Q4
$2.21M Sell
65,564
-3,123
-5% -$105K ﹤0.01% 1400
2023
Q3
$2.11M Sell
68,687
-1,446
-2% -$44.4K ﹤0.01% 1379
2023
Q2
$2.81M Buy
70,133
+2,367
+3% +$94.8K ﹤0.01% 1312
2023
Q1
$2.77M Buy
67,766
+3,189
+5% +$130K ﹤0.01% 1330
2022
Q4
$2.49M Sell
64,577
-9,446
-13% -$365K ﹤0.01% 1366
2022
Q3
$3.94M Buy
74,023
+8,785
+13% +$467K ﹤0.01% 1299
2022
Q2
$3.8M Sell
65,238
-6,079
-9% -$354K ﹤0.01% 1304
2022
Q1
$5.4M Sell
71,317
-3,356
-4% -$254K 0.01% 1281
2021
Q4
$4.49M Buy
74,673
+2,899
+4% +$174K ﹤0.01% 1351
2021
Q3
$4.02M Buy
71,774
+2,908
+4% +$163K ﹤0.01% 1386
2021
Q2
$4.18M Sell
68,866
-15,193
-18% -$922K ﹤0.01% 1405
2021
Q1
$5.89M Buy
84,059
+67,140
+397% +$4.71M 0.01% 1282
2020
Q4
$1.01M Sell
16,919
-893
-5% -$53.4K ﹤0.01% 1781
2020
Q3
$1.07M Buy
17,812
+5,089
+40% +$306K ﹤0.01% 1667
2020
Q2
$668K Sell
12,723
-11,095
-47% -$583K ﹤0.01% 1888
2020
Q1
$798K Buy
23,818
+11,999
+102% +$402K ﹤0.01% 1930
2019
Q4
$535K Buy
11,819
+2,974
+34% +$135K ﹤0.01% 1980
2019
Q3
$337K Buy
+8,845
New +$337K ﹤0.01% 2033
2016
Q3
Sell
-525
Closed -$18K 1822
2016
Q2
$18K Buy
525
+22
+4% +$754 ﹤0.01% 1600
2016
Q1
$27K Buy
503
+37
+8% +$1.99K ﹤0.01% 1586
2015
Q4
$36K Buy
466
+273
+141% +$21.1K ﹤0.01% 1609
2015
Q3
$8K Buy
193
+18
+10% +$746 ﹤0.01% 1609
2015
Q2
$12K Buy
+175
New +$12K ﹤0.01% 1616